• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,867.80 -141.90
( -0.19%)
Global Indices
Nasdaq
50,493.86 -106.84
(-0.21%)
Dow Jones
7,540.47 46.00
(0.61%)
Hang Seng
65,194.32 198.23
(0.30%)
Nikkei 225
10,507.74 16.35
(0.16%)
Forex
USD-INR
95.26 -0.35
(-0.37%)
EUR-INR
110.89 -0.08
(-0.07%)
GBP-INR
128.53 0.11
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.1556811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
15695.03
EPS(TTM)
Face Value()
Div & Yield %
1.97
1
0.51
 

biogen pharmachem industries ltd
Biogen Pharmachem Industries reports standalone net loss of Rs 0.36 crore in the March 2026 quarter
May 15,2026
Net loss of Biogen Pharmachem Industries reported to Rs 0.36 crore in the quarter ended March 2026 as against net profit of Rs 1.18 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.86 crore in the year ended March 2026 as against net loss of Rs 0.29 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.